The next major event isn't going to be more clinical trial results. We've just had a clinical trial result and no other clinical trials are underway. The next major event will be a licensing agreement for AML in a geographic region, including some cash upfront. This will happen because: * the AML proofs of concept are now sufficiently complete * RAC can't perform a loaves and fishes miracle; the cardioprotection and FTO programmes need more cash * the current SP isn't conducive to a CR.
RAC Price at posting:
97.0¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)